|
1
|
Lopez AD, Mathers CD, Ezzati M, Jamison DT
and Murray CJ: Global and regional burden of disease and risk
factors, 2001: Systematic analysis of population health data.
Lancet. 367:1747–1757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strauer BE and Steinhoff G: 10 years of
intracoronary and intramyocardial bone marrow stem cell therapy of
the heart: From the methodological origin to clinical practice. J
Am Coll Cardiol. 58:1095–1104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Menasché P: Current status and future
prospects for cell transplantation to prevent congestive heart
failure. Semin Thorac Cardiovasc Surg. 20:131–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem Cells. 24:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li C, Ma D, Chen M, Zhang L, Zhang L,
Zhang J, Qu X and Wang C: Ulinastatin attenuates LPS-induced human
endothelial cells oxidative damage through suppressing JNK/c-Jun
signaling pathway. Biochem Biophys Res Commun. 474:572–578. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu B, Huang W, Xiao X, Xu Y, Ma S and Xia
Z: Neuroprotective effect of ulinastatin on spinal cord
ischemia-reperfusion injury in rabbits. Oxid Med Cell Longev 2015.
6248192015.
|
|
7
|
Yu Z, Rayile A, Zhang X, Li Y and Zhao Q:
Ulinastatin protects against lipopolysaccharide-induced cardiac
microvascular endothelial cell dysfunction via downregulation of
lncRNA MALAT1 and EZH2 in sepsis. Int J Mol Med. 39:1269–1276.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Makino S, Fukuda K, Miyoshi S, Konishi F,
Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, et al:
Cardiomyocytes can be generated from marrow stromal cells in vitro.
J Clin Invest. 103:697–705. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu R, Yu BX, Chen JF, Lv XY, Yan ZJ, Cheng
Y and Ma Q: Anti-tumor effects of Atractylenolide I on bladder
cancer cells. J Exp Clin Cancer Res. 35:402016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garner TP, Lopez A, Reyna DE, Spitz AZ and
Gavathiotis E: Progress in targeting the BCL-2 family of proteins.
Curr Opin Chem Biol. 39:133–142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maekawa H and Inagi R: Stress signal
network between hypoxia and ER Stress in chronic kidney disease.
Front Physiol. 8:742017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shake JG, Gruber PJ, Baumgartner WA,
Senechal G, Meyers J, Redmond JM, Pittenger MF and Martin BJ:
Mesenchymal stem cell implantation in a swine myocardial infarct
model: Engraftment and functional effects. Ann Thorac Surg.
73:1919–1926. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Orlic D, Kajstura J, Chimenti S, Limana F,
Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A and Anversa
P: Mobilized bone marrow cells repair the infarcted heart,
improving function and survival. Proc Natl Acad Sci USA.
98:10344–10349. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marofi F, Vahedi G, Biglari A,
Esmaeilzadeh A and Athari SS: Mesenchymal stromal/stem cells: A new
era in the cell-based targeted gene therapy of cancer. Front
Immunol. 8:17702017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hale SL, Dai W, Dow JS and Kloner RA:
Mesenchymal stem cell administration at coronary artery reperfusion
in the rat by two delivery routes: A quantitative assessment. Life
Sci. 83:511–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hodgetts SI, Beilharz MW, Scalzo AA and
Grounds MD: Why do cultured transplanted myoblasts die in vivo? DNA
quantification shows enhanced survival of donor male myoblasts in
host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell
Transplant. 9:489–502. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang YL, Tang Y, Zhang YC, Qian K, Shen L
and Phillips MI: Improved graft mesenchymal stem cell survival in
ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J
Am Coll Cardiol. 46:1339–1350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng K, Deng BP, Jiang HQ, Wang M, Hua P,
Zhang HW, Deng YB and Yang YQ: Prostaglandin E1 protects
bone marrow-derived mesenchymal stem cells against serum
deprivation-induced apoptosis. Mol Med Rep. 12:5723–5729. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang F, Cui J, Lv B and Yu B: Nicorandil
protects mesenchymal stem cells against hypoxia and serum
deprivation-induced apoptosis. Int J Mol Med. 36:415–423. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inoue K and Takano H: Urinary trypsin
inhibitor as a therapeutic option for endotoxin-related
inflammatory disorders. Expert Opin Investig Drugs. 19:513–520.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inoue K, Takano H, Yanagisawa R and
Yoshikawa T: Protective effects of urinary trypsin inhibitor on
systemic inflammatory response induced by lipopolysaccharide. J
Clin Biochem Nutr. 43:139–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Atal SS and Atal S: Ulinastatin-a newer
potential therapeutic option for multiple organ dysfunction
syndrome. J Basic Clin Physiol Pharmacol. 27:91–99. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bialik S, Cryns VL, Drincic A, Miyata S,
Wollowick AL, Srinivasan A and Kitsis RN: The mitochondrial
apoptotic pathway is activated by serum and glucose deprivation in
cardiac myocytes. Circ Res. 85:403–414. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen CC, Liu ZM, Wang HH, He W, Wang Y and
Wu WD: Effects of ulinastatin on renal ischemia-reperfusion injury
in rats. Acta Pharmacol Sin. 25:1334–1340. 2004.PubMed/NCBI
|
|
25
|
Merksamer PI, Trusina A and Papa FR:
Real-time redox measurements during endoplasmic reticulum stress
reveal interlinked protein folding functions. Cell. 135:933–947.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Badiola N, Penas C, Miñano-Molina A,
Barneda-Zahonero B, Fadó R, Sánchez-Opazo G, Comella JX, Sabriá J,
Zhu C, Blomgren K, et al: Induction of ER stress in response to
oxygen-glucose deprivation of cortical cultures involves the
activation of the PERK and IRE-1 pathways and of caspase-12. Cell
Death Dis. 2:e1492011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Motegi SI, Sekiguchi A, Uchiyama A, Uehara
A, Fujiwara C, Yamazaki S, Perera B, Nakamura H, Ogino S, Yokoyama
Y, et al: Protective effect of mesenchymal stem cells on the
pressure ulcer formation by the regulation of oxidative and
endoplasmic reticulum stress. Sci Rep. 7:171862017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sears TK and Angelastro JM: The
transcription factor ATF5: Role in cellular differentiation, stress
responses, and cancer. Oncotarget. 8:84595–84609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Franke TF, Kaplan DR and Cantley LC: PI3K:
Downstream AKTion blocks apoptosis. Cell. 88:435–437. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH,
Joo SY, Nam KI, Cho JG, Kang PM and Park JC: The effects of
mesenchymal stem cells transduced with Akt in a porcine myocardial
infarction model. Cardiovasc Res. 70:530–542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen J, Crawford R, Chen C and Xiao Y: The
key regulatory roles of the PI3K/Akt signaling pathway in the
functionalities of mesenchymal stem cells and applications in
tissue regeneration. Tissue Eng Part B Rev. 19:516–528. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo Z, Li CS, Wang CM, Xie YJ and Wang AL:
CSE/H2S system protects mesenchymal stem cells from hypoxia and
serum deprivation-induced apoptosis via mitochondrial injury,
endoplasmic reticulum stress and PI3K/Akt activation pathways. Mol
Med Rep. 12:2128–2134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maksimovic-Ivanic D, Fagone P, McCubrey Y,
Bendtzen K, Mijatovic S and Nicoletti F: HIV-protease inhibitors
for the treatment of cancer: Repositioning HIV protease inhibitors
while developing more potent NO-hybridized derivatives? Int J
Cancer. 140:1713–1726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discovery Today. 16:715–721. 2017. View Article : Google Scholar
|
|
35
|
Donia M, McCubrey JA, Bendtzen K and
Nicoletti F: Potential use of rapamycin in HIV infection. Br J Clin
Pharmacol. 70:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu Y, Yu X, Ma J, Tong Y and Yao J:
Effects of NVP-BEZ235 on the proliferation, migration, apoptosis
and autophagy in HT-29 humancolorectal adenocarcinoma cells. Int J
Oncol. 49:285–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
